Public Employees Retirement System of Ohio Decreases Position in Encompass Health Co. (NYSE:EHC)

Public Employees Retirement System of Ohio decreased its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 11.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,316 shares of the company's stock after selling 4,730 shares during the quarter. Public Employees Retirement System of Ohio's holdings in Encompass Health were worth $3,354,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Colonial Trust Co SC purchased a new stake in Encompass Health in the 4th quarter worth approximately $29,000. Transce3nd LLC purchased a new stake in Encompass Health in the 4th quarter worth approximately $40,000. CBIZ Investment Advisory Services LLC boosted its position in Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares in the last quarter. V Square Quantitative Management LLC boosted its position in Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after purchasing an additional 177 shares in the last quarter. Finally, Signaturefd LLC boosted its position in Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after purchasing an additional 125 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Encompass Health Trading Down 0.2%

Shares of EHC traded down $0.25 during midday trading on Wednesday, reaching $121.26. The company had a trading volume of 573,478 shares, compared to its average volume of 701,028. Encompass Health Co. has a 1-year low of $82.74 and a 1-year high of $123.11. The stock has a market cap of $12.22 billion, a PE ratio of 27.19, a price-to-earnings-growth ratio of 2.31 and a beta of 0.89. The firm has a 50 day simple moving average of $111.16 and a 200-day simple moving average of $102.43. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. The business had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The company's revenue was up 10.6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.12 EPS. Research analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date is Tuesday, July 1st. Encompass Health's dividend payout ratio is presently 14.05%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on EHC. Royal Bank of Canada upped their target price on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Barclays upped their target price on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research note on Friday, April 25th. KeyCorp upped their target price on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 27th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, Truist Financial reaffirmed a "buy" rating and set a $135.00 target price (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Eight analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $122.71.

Insider Activity at Encompass Health

In other news, CEO Mark J. Tarr sold 118,384 shares of Encompass Health stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the transaction, the chief executive officer now owns 527,070 shares in the company, valued at approximately $64,054,817.10. This trade represents a 18.34% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total value of $1,147,900.00. Following the completion of the transaction, the executive vice president now owns 79,710 shares of the company's stock, valued at $9,149,910.90. The trade was a 11.15% decrease in their position. The disclosure for this sale can be found here. Insiders sold 132,663 shares of company stock worth $16,034,082 in the last three months. 2.10% of the stock is owned by company insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.